Polaris Partners VII, L.P.
Related Filers (6)
- Polaris Entrepreneurs' Fund VII, L.P. (6)
- Polaris Management Co. VII, L.L.C. (6)
- Syros Pharmaceuticals, Inc. (4)
- Metacrine, Inc. (3)
- Morphic Holding, Inc. (3)
- SQZ Biotechnologies Co (2)
- Show More ...
Other (3)
D/A
Thursday, 2/12/2015
Exempt (Private) Offering
D/A
Wednesday, 6/25/2014
Exempt (Private) Offering
D
Tuesday, 6/24/2014
Exempt (Private) Offering
Ownership (12)
SC 13G/A
Friday, 2/9/2024
Morphic Holding, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Morphic Holding, Inc.: Major Shareholders
SC 13G
Friday, 2/12/2021
Metacrine, Inc.: Major Shareholders
4
Tuesday, 11/3/2020
SQZ Biotechnologies Co: Statement of changes in beneficial ownership of securities
3
Thursday, 10/29/2020
SQZ Biotechnologies Co: Initial statement of beneficial ownership of securities
4
Tuesday, 9/22/2020
Metacrine, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/15/2020
Metacrine, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Wednesday, 2/12/2020
Morphic Holding, Inc.: Major Shareholders
SC 13D/A
Thursday, 2/14/2019
Syros Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Thursday, 7/14/2016
Syros Pharmaceuticals, Inc.: Major Shareholders
4
Thursday, 7/7/2016
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/29/2016
Syros Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities